Pure Global AI
ANVISA registration 10033121103Valid until Jun 22, 2036

HUMAN BRAIN NATRIURETIC PEPTIDE (BNP)

ANVISA Registration Number: 10033121103BECKMAN COULTER DO BRASIL COMÉRCIO E IMPORTAÇÃO DE PRODUTOS DE LABORATÓRIO LTDABECKMAN COULTER INCRisk Class III
Verified
Device names
Technical name
HUMAN BRAIN NATRIURETIC PEPTIDE (BNP)
View exact technical-name matches →
PT: PEPTÍDEO NATRIURÉTICO CEREBRAL HUMANO (BNP)
Commercial name
Access BNP II
View exact commercial-name matches →
Risk class
Class III
Registration details
Registration Number
10033121103
Process Number
25351078866202614
CNPJ
42160812000144
Company information
Registration Holder
BECKMAN COULTER DO BRASIL COMÉRCIO E IMPORTAÇÃO DE PRODUTOS DE LABORATÓRIO LTDA
Manufacturer
BECKMAN COULTER INC
Manufacturing Country
United States
PT: ESTADOS UNIDOS DA AMÉRICA
Dates and status
Publication Date
Jun 22, 2026
Validity
22/06/2036
Last Updated
08/18/2026 19:00:00
About this record

Access comprehensive regulatory information for HUMAN BRAIN NATRIURETIC PEPTIDE (BNP) in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10033121103 and manufactured by BECKMAN COULTER INC. The registration is held by BECKMAN COULTER DO BRASIL COMÉRCIO E IMPORTAÇÃO DE PRODUTOS DE LABORATÓRIO LTDA with validity until Jun 22, 2036.

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.